Cargando…
Gene Therapy in a Mouse Model of Niemann–Pick Disease Type C1
Niemann–Pick disease type C1 (NPC1) is a fatal congenital neurodegenerative disorder caused by mutations in the NPC1 gene, which is involved in cholesterol transport in lysosomes. Broad clinical manifestations of NPC1 include liver failure, pulmonary disorder, neurological deficits, and psychiatric...
Autores principales: | Kurokawa, Yoshie, Osaka, Hitoshi, Kouga, Takeshi, Jimbo, Eriko, Muramatsu, Kazuhiro, Nakamura, Sachie, Takayanagi, Yuki, Onaka, Tatsushi, Muramatsu, Shin-ichi, Yamagata, Takanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236559/ https://www.ncbi.nlm.nih.gov/pubmed/33256498 http://dx.doi.org/10.1089/hum.2020.175 |
Ejemplares similares
-
Gene therapy for a mouse model of glucose transporter-1 deficiency syndrome
por: Nakamura, Sachie, et al.
Publicado: (2017) -
Drug screening for Pelizaeus-Merzbacher disease by quantifying the total levels and membrane localization of PLP1
por: Kouga, Takeshi, et al.
Publicado: (2019) -
WDR45 variants cause ferrous iron loss due to impaired ferritinophagy associated with nuclear receptor coactivator 4 and WD repeat domain phosphoinositide interacting protein 4 reduction
por: Tsukida, Kiwako, et al.
Publicado: (2022) -
Dopaminergic restoration of prefrontal cortico-putaminal network in gene therapy for aromatic l-amino acid decarboxylase deficiency
por: Onuki, Yoshiyuki, et al.
Publicado: (2021) -
Role of oxytocin in the control of stress and food intake
por: Onaka, Tatsushi, et al.
Publicado: (2019)